Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00062062
Protocol Section: NCT00062062
Start Identification Module Data
Brief Title: Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
Official Title: Parallel Phase II Trials of ZD1839 Iressa Alone or Weekly Carboplatin and Paclitaxel Followed by ZD1839 Iressa Oncologists Must Choose for Metastatic Non-Small Cell Lung Cancer in Patients or 65 Years of Age
Acronym: None
Organization: Alliance for Clinical Trials in Oncology
Organization Class: OTHER
Organization Study ID: NCCTG-N0222
Secondary IDs
Secondary ID Type Domain Link
CDR0000304453 REGISTRY PDQ Physician Data Query None
NCI-2012-02535 REGISTRY None None
Start Status Module Data
Status Verified Date: 2016-12
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Alliance for Clinical Trials in Oncology
Lead Sponsor Class: OTHER
Lead Sponsor: Alliance for Clinical Trials in Oncology
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload